CLDI (Calidi Biotherapeutics, Inc.) Stock Analysis - SEC Filings

Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of May 21, 2026, CLDI trades at $0.18 with a market cap of $2.79M and a P/E ratio of -0.03. CLDI moved -8.04% today. Year to date, CLDI is -85.53%; over the trailing twelve months it is -96.84%. Its 52-week range spans $0.16 to $46.68. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CLDI SEC filings?

Rallies organizes CLDI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CLDI Key Metrics

Key financial metrics for CLDI
MetricValue
Price$0.18
Market Cap$2.79M
P/E Ratio-0.03
EPS$-5.95
Dividend Yield0.00%
52-Week High$46.68
52-Week Low$0.16
Volume186.46K
Avg Volume0
Revenue (TTM)$0
Net Income$-20.06M
Gross Margin0.00%

Latest CLDI News

Recent CLDI Insider Trades

  • Camaisa Allan sold 850 (~$1.24K) on Dec 12, 2025.
  • Schoeneck James A bought 75.00K (~$150.00K) on Aug 21, 2025.
  • Poma Eric E bought 25.00K (~$50.00K) on Aug 21, 2025.

CLDI Analyst Consensus

CLDI analyst coverage data. Average price target: $0.00.

Common questions about CLDI

Where can I find CLDI SEC filings?
Rallies organizes CLDI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CLDI 10-K and 10-Q filings?
Rallies organizes CLDI SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CLDI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLDI. It does not provide personalized investment advice.
CLDI

CLDI